65 related articles for article (PubMed ID: 23957430)
1. Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1-ALK fusion variant.
Yoshida A; Shibata T; Tsuta K; Watanabe S; Tsuda H
Histopathology; 2013 Dec; 63(6):881-3. PubMed ID: 23957430
[No Abstract] [Full Text] [Related]
2. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
[TBL] [Abstract][Full Text] [Related]
3. A cutaneous inflammatory myofibroblastic tumour with ALK rearrangement in the upper extremity.
Cantile M; Aquino G; Franco R; Marra L; Gallo M; De Chiara A
Pathology; 2014 Oct; 46(6):575-6. PubMed ID: 25158817
[No Abstract] [Full Text] [Related]
4. A case of an inflammatory myofibroblastic tumor in the lung which expressed TPM3-ALK gene fusion.
Kinoshita Y; Tajiri T; Ieiri S; Nagata K; Taguchi T; Suita S; Yamazaki K; Yoshino I; Maehara Y; Kohashi K; Yamamoto H; Oda Y; Tsuneyoshi M
Pediatr Surg Int; 2007 Jun; 23(6):595-9. PubMed ID: 17063337
[TBL] [Abstract][Full Text] [Related]
5. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.
Panagopoulos I; Nilsson T; Domanski HA; Isaksson M; Lindblom P; Mertens F; Mandahl N
Int J Cancer; 2006 Mar; 118(5):1181-6. PubMed ID: 16161041
[TBL] [Abstract][Full Text] [Related]
6. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset inflammatory myofibroblastic tumour of the stomach with a TFG-ROS1 fusion.
Fujita H; Yoshida A; Taniguchi H; Katai H; Sekine S
Histopathology; 2015 Mar; 66(4):610-2. PubMed ID: 25293980
[No Abstract] [Full Text] [Related]
8. Inflammatory myofibroblastic tumour of the testis with confirmed anaplastic lymphoma kinase gene rearrangement.
Hickman RA; Alexander M; Provet J; Melamed J; Deng FM
Histopathology; 2016 Jun; 68(7):1109-11. PubMed ID: 26444540
[No Abstract] [Full Text] [Related]
9. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer.
Lira ME; Kim TM; Huang D; Deng S; Koh Y; Jang B; Go H; Lee SH; Chung DH; Kim WH; Schoenmakers EF; Choi YL; Park K; Ahn JS; Sun JM; Ahn MJ; Kim DW; Mao M
J Mol Diagn; 2013 Jan; 15(1):51-61. PubMed ID: 23246132
[TBL] [Abstract][Full Text] [Related]
11. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
Chen ST; Lee JC
Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
[TBL] [Abstract][Full Text] [Related]
12. ALK status in a primary lung tumour and metachronous metastases.
Salido M; Pijuan L; Galván AB; Gimeno J; Cañadas I; Rodriguez-Rivera M; Rojo F; Albanell J; Solé F; Arriola E
Histopathology; 2012 Apr; 60(5):843-5. PubMed ID: 22236334
[No Abstract] [Full Text] [Related]
13. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
[TBL] [Abstract][Full Text] [Related]
14. Targeting anaplastic lymphoma kinase in lung cancer.
Shaw AT; Solomon B
Clin Cancer Res; 2011 Apr; 17(8):2081-6. PubMed ID: 21288922
[TBL] [Abstract][Full Text] [Related]
15. Malignant high-grade histological transformation of inflammatory myofibroblastic tumour associated with amplification of TPM3-ALK.
Zhang H; Erickson-Johnson M; Wang X; Bahrami A; Medeiros F; Lonzo ML; Oliveira AM
J Clin Pathol; 2010 Nov; 63(11):1040-1. PubMed ID: 20870660
[No Abstract] [Full Text] [Related]
16. Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
Yamamoto M; Takeuchi K; Shimoji M; Maniwa T; Isaka M; Nakagawa K; Ohde Y; Kondo H; Nakajima T
Cancer Sci; 2012 Feb; 103(2):390-2. PubMed ID: 22296236
[TBL] [Abstract][Full Text] [Related]
17. Genetically informed lung cancer medicine.
Pao W; Iafrate AJ; Su Z
J Pathol; 2011 Jan; 223(2):230-40. PubMed ID: 21125677
[TBL] [Abstract][Full Text] [Related]
18. Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.
Yamada T; Takeuchi S; Nakade J; Kita K; Nakagawa T; Nanjo S; Nakamura T; Matsumoto K; Soda M; Mano H; Uenaka T; Yano S
Clin Cancer Res; 2012 Jul; 18(13):3592-602. PubMed ID: 22553343
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory myofibroblastic tumour: a rare entity with wide differential diagnosis.
Gilani SM; Kowalski PJ
Pathologica; 2014 Mar; 106(1):1-6. PubMed ID: 24897773
[TBL] [Abstract][Full Text] [Related]
20. Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
Jedrych J; Nikiforova M; Kennedy TF; Ho J
Br J Dermatol; 2015; 172(5):1427-9. PubMed ID: 25413595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
